Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers

The antiproliferative effects of an antagonist of growth hormone-releasing hormone (GHRH) JV-1-38 were evaluated in nude mice bearing s.c. xenografts of LNCaP and MDA-PCa-2b human androgen-sensitive and DU-145 androgen-independent prostate cancers. In the androgen-sensitive models, JV-1-38 greatly p...

Celý popis

Podrobná bibliografie

Vydáno v:	Proc Natl Acad Sci U S A
Hlavní autoři:	Letsch, Markus, Schally, Andrew V., Busto, Rebeca, Bajo, Ana M., Varga, Jozsef L.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	National Academy of Sciences 2003
Témata:	Biological Sciences
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC298759/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12538852/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.0337496100
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!